The ‘High-Functioning’ Flare: Why Settling for ‘Good Enough’ Atopic Dermatitis Care Is Costing You

The ‘High-Functioning’ Flare: Why Settling for ‘Good Enough’ Atopic Dermatitis Care Is Costing You

The ‘High-Functioning’ Flare: Why Settling for ‘Good Enough’ Atopic Dermatitis Care Is Costing You
iStock
Atopic dermatitis (AD) is mainly characterized by cycles of skin rashes, intense itching, dryness, and skin sensitivity. But this chronic and relapsing condition can come with hidden challenges as well, including poor sleep, lost focus, and significant mental health effects.

"Quality of life is a major consideration with atopic dermatitis because the condition can be highly disruptive, especially if symptoms return quickly once treatment stops or surface-level treatments alone are no longer enough," says Alexandra Bowles, DO, a dermatologist at MONA Dermatology in Cincinnati.

This creates an emotional burden, particularly for professionals who have to mask symptoms under business attire. For example, research suggests that productivity decreases as AD becomes more severe.

 The good news is that there are ways to move beyond merely surviving AD, by working with your health team to regain self-confidence.

How to Recognize Signs of Ineffective Treatment

One of the first steps in navigating beyond "good enough" AD treatment is recognizing when it may be time for a treatment switch. Dr. Bowles says signs can include:

  • Flares become more frequent, last longer, or both.
  • Symptoms are increasingly difficult to control despite consistent use of topical therapies and good skin-care habits.
  • Sleep is disrupted by itching and discomfort.
  • Itching is intense enough to cause cracked or scratched skin that becomes prone to infection.
  • Medications seem to cause more side effects than relief.

Another indication that your treatment needs to change is a negative impact on daily activities and emotional well-being, says Kellie Reed, MD, a dermatologist at Westlake Dermatology in Austin, Texas. This might take the form of reduced confidence, lack of focus, and self-consciousness about trying to hide or minimize symptoms, particularly in a work setting.

It can be helpful to keep a treatment diary, says Dr. Reed. Log your skin-related symptoms and note how long a topical treatment brings your relief. But also record issues like professional difficulties and sleep quality problems. Specific, comprehensive insights into all the many effects of AD can help drive more productive conversations with your dermatologist and healthcare team, she says.

Newest Treatment Options

Systemic therapy is generally considered if you have moderate to severe disease with frequent or severe flares, says Tanya Evans, MD, a dermatologist and the medical director of the skin cancer program at the Melanoma Clinic at MemorialCare Saddleback Medical Center in Laguna Hills, California.

Newer oral therapies known as JAK inhibitors work by targeting specific inflammatory signaling pathways involved in AD.

 These medications can help reduce inflammation and itch more directly and often quicker than traditional treatments, Dr. Evans says. Options approved by the U.S. Food and Drug Administration include upadacitinib (Rinvoq) and abrocitinib (Cibinqo).

"New systemic therapies, especially JAK inhibitors, are transforming treatment for moderate to severe atopic dermatitis by offering rapid symptom relief and high efficacy," explains Evans. "However, they require an understanding of whether you're a good candidate, and ongoing monitoring to balance benefits with potential side effects." She says these may include:

  • Nausea
  • High blood pressure
  • Headache
  • Diarrhea
  • Increased risk of infections
While oral JAK inhibitors are the newest class of systemic therapy for moderate to severe atopic dermatitis, other options include the injected biologics dupilumab (Dupixent), lebrikizumab (Ebglyss), tralokinumab (Adbry), and nemolizumab (Nemluvio), as well as oral immune-suppressing drugs.

It's important to keep in mind that systemic therapies don’t replace good skin care, they work alongside it, says Bowles.

"Even when someone starts an oral medication, maintaining a gentle, consistent skin care routine remains essential to support the skin barrier and reduce irritation," she says. "That includes regular moisturizing, avoiding harsh cleansers, and minimizing known triggers. The most effective approach is a layered one that addresses both internal inflammation and external barrier support."

Shared Decision-Making

You don’t have to settle for incomplete symptom control and pushing through flares. If you’re considering switching treatment for atopic dermatitis, it helps to create a list of questions around your treatment goals you can take to your next dermatology appointment.

Questions to Ask Your Dermatologist

  • Is clear skin a realistic goal, rather than skin that's simply less itchy or has reduced inflammation?
  • What are my options for switching medications? Would an option like JAK inhibitors be a fit for me and my AD?
  • If I use these new medications, when can I expect to see improvement? 
  • What common side effects do these medications cause? Are there rare side effects I should know about?
  • Would a JAK inhibitor be a long-term solution for controlling my flares?
  • What lifestyle habits are important as a complement to medications?
"Not everyone is a candidate for oral JAK inhibitors," says Reed. "Because of that, always be sure to discuss this with your dermatologist, to see if they're a good fit for you, as well as other treatments that may help to move you past 'good enough' AD management."

The Takeaway

  • With "high-functioning flares," your AD symptom management is less than ideal, which can take a toll on your mental health and productivity.
  • Oral therapies such as JAK inhibitors offer new ways to stop the itch-scratch cycle and manage chronic inflammation.
  • Keep track of your symptoms and plan questions in advance to make discussions with your dermatologist more productive.

Resources We Trust

EDITORIAL SOURCES
Everyday Health follows strict sourcing guidelines to ensure the accuracy of its content, outlined in our editorial policy. We use only trustworthy sources, including peer-reviewed studies, board-certified medical experts, patients with lived experience, and information from top institutions.
Resources
  1. LeBovidge JS et al. Depression and Anxiety in Patients with Atopic Dermatitis. Annals of Allergy, Asthma & Immunology. May 2025.
  2. Naik H et al. Work Productivity Loss and Health-Related Quality of Life in People Living with Atopic Dermatitis: A Canada-Wide Cross-Sectional Study. Dermatitis: Contact, Atopic, Occupational, Drug. November 26, 2025.
  3. Shawky AM et al. A Comprehensive Overview of Globally Approved JAK Inhibitors. Pharmaceutics. May 6, 2022.
  4. Ludmann P. Eczema Types: Atopic Dermatitis Diagnosis and Treatment. American Academy of Dermatology Association. September 24, 2025.
Susan-Bard-bio

Susan Bard, MD

Medical Reviewer

Susan Bard, MD, is a clinical instructor in the department of dermatology at Weill Cornell Medicine and an adjunct clinical instructor in the department of dermatology at Mount Sinai in New York City. Her professional interests include Mohs micrographic surgery, cosmetic and laser procedures, and immunodermatology.

She is a procedural dermatologist with the American Board of Dermatology and a fellow of the American College of Mohs Surgery.

Dr. Bard has written numerous book chapters and articles for many prominent peer-reviewed journals, and authored the textbook The Laser Treatment of Vascular Lesions.

elizabeth-millard-bio

Elizabeth Millard

Author

Elizabeth Millard is a Minnesota-based freelance health writer. Her work has appeared in national outlets and medical institutions including Time, Women‘s Health, Self, Runner‘s World, Prevention, and more. She is an ACE Certified Personal Trainer and a Yoga Alliance Registered Yoga Teacher, and is trained in obesity management.